agalsidase α
Recently Published Documents


TOTAL DOCUMENTS

10
(FIVE YEARS 1)

H-INDEX

2
(FIVE YEARS 0)

2021 ◽  
Vol 22 (5) ◽  
pp. 2680
Author(s):  
Malte Lenders ◽  
David Scharnetzki ◽  
Ali Heidari ◽  
Daniele Di Iorio ◽  
Seraphine Valeska Wegner ◽  
...  

Male patients with Fabry disease (FD) are at high risk for the formation of antibodies to recombinant α-galactosidase A (AGAL), used for enzyme replacement therapy. Due to the rapid disease progression, the identification of patients at risk is highly warranted. However, currently suitable references and standardized protocols for anti-drug antibodies (ADA) determination do not exist. Here we generate a comprehensive patient-derived antibody mixture as a reference, allowing ELISA-based quantification of antibody titers from individual blood samples. Serum samples of 22 male patients with FD and ADAs against AGAL were pooled and purified by immune adsorption. ADA-affinities against agalsidase-α, agalsidase-β and Moss-AGAL were measured by quartz crystal microbalance with dissipation monitoring (QCM-D). AGAL-specific immune adsorption generated a polyclonal ADA mixture showing a concentration-dependent binding and inhibition of AGAL. Titers in raw sera and from purified total IgGs (r2 = 0.9063 and r2 = 0.8952, both p < 0.0001) correlated with the individual inhibitory capacities of ADAs. QCM-D measurements demonstrated comparable affinities of the reference antibody for agalsidase-α, agalsidase-β and Moss-AGAL (KD: 1.94 ± 0.11 µM, 2.46 ± 0.21 µM, and 1.33 ± 0.09 µM, respectively). The reference antibody allows the ELISA-based ADA titer determination and quantification of absolute concentrations. Furthermore, ADAs from patients with FD have comparable affinities to agalsidase-α, agalsidase-β and Moss-AGAL.


eLife ◽  
2018 ◽  
Vol 7 ◽  
Author(s):  
Lukas Hofmann ◽  
Dorothea Hose ◽  
Anne Grießhammer ◽  
Robert Blum ◽  
Frank Döring ◽  
...  

Fabry disease (FD) is a life-threatening X-linked lysosomal storage disorder caused by α-galactosidase A (α-GAL) deficiency. Small fiber pathology and pain are major FD symptoms of unknown pathophysiology. α-GAL deficient mice (GLA KO) age-dependently accumulate globotriaosylceramide (Gb3) in dorsal root ganglion (DRG) neurons paralleled by endoplasmic stress and apoptosis as contributors to skin denervation. Old GLA KO mice show increased TRPV1 protein in DRG neurons and heat hypersensitivity upon i.pl. capsaicin. In turn, GLA KO mice are protected from heat and mechanical hypersensitivity in neuropathic and inflammatory pain models based on reduced neuronal Ih and Nav1.7 currents. We show that in vitro α-GAL silencing increases intracellular Gb3 accumulation paralleled by loss of Nav1.7 currents, which is reversed by incubation with agalsidase-α and lucerastat. We provide first evidence of a direct Gb3 effect on neuronal integrity and ion channel function as potential mechanism underlying pain and small fiber pathology in FD.


2017 ◽  
Vol 149 (6) ◽  
pp. 270
Author(s):  
Jordi Pérez-López ◽  
Alfonso Domínguez Gil-Hurlé ◽  
Mónica López Rodríguez

2016 ◽  
Vol 1620 (1) ◽  
pp. 14-14
Keyword(s):  

2013 ◽  
Vol 1470 (1) ◽  
pp. 5-5
Keyword(s):  

2011 ◽  
Vol &NA; (1352) ◽  
pp. 6-7
Author(s):  
&NA;
Keyword(s):  

2010 ◽  
Vol &NA; (1286) ◽  
pp. 8
Author(s):  
&NA;
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document